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We investigated the inhibition of advanced glycation endproduct (AGE) activity using the fluorescence characteristics of fractions
and compounds from Corni Fructus. Corni Fructus extract and its iridoid glycoside components showed low inhibitory activities
as well as the AGE inhibitor aminoguanidine. However, a low molecular weight polyphenol, 7-O-galloyl-d-sedoheptulose, and
an antioxidant, trolox, showed high inhibitory activities compared with aminoguanidine under reactive conditions. The AGE-
inhibiting activity of polyphenolic fractions of Corni Fructus ranged from a level comparable to Corni Fructus extract to
the higher level of 7-O-galloyl-d-sedoheptulose. As well as the results of AGE-inhibiting activity, Corni Fructus extract and
iridoid components showed low or no 1,1-diphenyl-2-pycrylhydrazyl (DPPH) radical-scavenging activities, whereas 7-O-galloyl-
d-sedoheptulose showed a level comparable to trolox. Polyphenolic fractions of Corni Fructus quenched DPPH radicals in a
concentration-dependent manner. Some fractions exerted a higher DPPH radical-scavenging activity compared with trolox and
7-O-galloyl-d-sedoheptulose. The DPPH radical-scavenging activity was significantly correlated with the AGE-inhibiting activity.
These results suggest that polyphenolic fractions of Corni Fructus inhibited AGE formation by antioxidant activity including
free radical scavenging. The strong DPPH radical-scavenging and AGE-inhibiting fractions included ellagitannins and polymeric
proanthocyanidins.
1. Introduction
The advanced glycation endproduct (AGE), which is the
nonenzymatic modification of proteins by reducing sugars,
plays an important role in the development of chronic
diabetic complications [1, 2] and aging [2]. Therefore, the
inhibition of AGE formation may be a promising target for
therapeutic intervention in these AGE-related disorders.
AGE inhibitors may act through various mechanisms at
different steps of AGE formation and AGE-mediated dam-
age, such as the trapping of reactive dicarbonyl species,
antioxidant activity by transition metal chelation, other
antioxidant activity including free radical scavenging, AGE
cross-link cleavage, AGE receptor blocking, AGE signaling
blocking, glycemia reduction by antidiabetic therapy, aldose
reductase inhibition, and shunting of trioses-P towards the
pentose-P pathway by transketolase activation [3]. Although
some AGE inhibitors such as aminoguanidine, OPB-9195,
LR compounds (LR-90, LR-9, and LR-74), and TM2002 have
been developed, no agent is used for diabetic complications
in Japan at the present time. One of the reasons for the
difficulty in the development of AGE inhibitors is the side
effects. In the case of aminoguanidine, a phase III clinical
trial was started [4]; however, the study was discontin-
ued due to safety concerns and an apparent lack of efficacy
[3].
From this standpoint, traditional medicines and their
components have the advantage that they act against the
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development of AGE without side effects. We have inves-
tigated the therapeutic potential of traditional medicines
against diabetic nephropathy associated with oxidative stress
and AGE formation. We previously reported the effects of
12 oriental medicines and their galenicals on the produc-
tion of AGE in vitro, and polyphenol-containing galenicals
exerted high-level inhibitory activity against AGE produc-
tion, assumed to be due to the elimination of free radicals
[5]. Since polyphenols exerted marked radical-scavenging
activity [6, 7], this suggested the involvement of antioxidant
activity, including free radical scavenging, in AGE inhibition
by polyphenols.
In subsequent studies, the Chinese prescription Hachi-
mi-jio-gan, which is prescribed for diabetes and diabetic
nephropathy, exhibited potential therapeutic effects against
metabolic disorders, especially AGE formation [8]. In addi-
tion, Corni Fructus, which is an ingredient of Hachimi-jio-
gan and has been used as a functional food, showed beneficial
effects on renal metabolic abnormalities including AGE
formation in streptozotocin-induced diabetic rats as well as
those of Hachimi-jio-gan [9, 10]. Corni Fructus is known to
contain iridoid glycosides, such as morroniside and loganin,
and polyphenolic compounds. Morroniside can prevent
diabetic renal damage via inhibiting AGE-receptor for AGE
(RAGE) binding rather than AGE formation as well as
oxidative stress in type 1 diabetic rats [11]. Moreover, loganin
can prevent diabetic hepatic damage via inhibiting AGE and
RAGE through improving hyperglycemia and dyslipidemia
in type 2 diabetic mice [12]. On the other hand, polyphenolic
compounds, such as 7-O-galloyl-d-sedoheptulose, proan-
thocyanidins, and ellagitannins, were also isolated [13–
15]. Recently, we reported that 7-O-galloyl-d-sedoheptulose
shows a lipid-lowering effect on the liver in hypertriglyceri-
demic rats, and a protective effect against oxidative stress
[16], AGE and RAGE in the liver or kidney of type 1 and 2
diabetic animal models [17, 18]. The polyphenolic fraction
containing polymeric proanthocyanidins has the potential
to suppress postprandial hyperglycemia, which facilitates
AGE formation [19]. These results indicate that several con-
stituents of Corni Fructus inhibit AGE formation by different
mechanisms. AGE formation is increased under conditions
of oxidative stress [20]. Glycation and oxidative stress are
closely linked and are often referred to as “glycoxidation”
processes. All glycation steps generate oxygen-free radicals
[21]. In addition, phenolic-rich plants have tended to have
antioxidant and antiglycation activity. Therefore, to eluci-
date the effects of fractions and compounds from Corni
Fructus against AGE formation, we investigated the AGE-
inhibiting activity using fluorescence characteristics, and also
radical-scavenging activity using the stable 1,1-diphenyl-2-
pycrylhydrazyl (DPPH) radical.
2. Materials and Methods
2.1. General. Column chromatography was performed using
Diaion HP20SS (Mitsubishi Chemical, Tokyo, Japan), Se-
phadex LH-20 (25–100 μm, GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) and Chromatorex ODS-MT (100–200
mesh; Fuji Silysia Chemical, Kasugai, Japan) columns. Thin-
layer chromatography (TLC) was performed on 0.2-mm-
thick precoated Kieselgel 60 F254 plates (Merck, Darmstadt,
Germany) using toluene-ethyl formate-formic acid (1 : 7 : 1,
v/v) or chloroform-MeOH-H2O (14 : 6 : 1, v/v). Spots were
detected by UV illumination, sprayed with 2% methanolic
FeCl3 or 10% sulfuric acid reagent, and then heated. Analyti-
cal reverse-phase HPLC was performed on a Cosmosil 5C18-
AR II column (Nacalai Tesque Inc., Kyoto, Japan; 4.6 mm
i.d. × 250 mm) using an elution gradient of 4–30% (39 min)
and 30–75% (15 min) CH3CN in 50 mM H3PO4 (flow rate:
0.8 mL/min; detection using the JASCO photodiode array
detector MD-910). Gel permeation column chromatography
was performed with a TSK-gel α3000 column (300× 7.8 mm
i.d.) at 40◦C with dimethylformamide containing 10 mM
LiCl as the elution solvent at a flow rate of 0.5 mL/min. The
peaks were detected by monitoring UV absorption at
254 nm. Polystyrene standards (molecular weights of 4,000,
25,000, 50,000, and 170,000), and toluene (molecular weight
of 92) were used as standards. The molecular weights
were recorded and calculated employing integrator 807-IT
(JASCO Corporation). The 1H- and 13C-NMR spectra were
recorded in a mixture of acetone-d6 and D2O (19 : 1, v/v)
at 27◦C with a JEOL JNM-AL400 spectrometer operating at
400 MHz for 1H and 100 MHz for 13C (JEOL Ltd., Tokyo,
Japan). Aminoguanidine and trolox were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). DPPH was pur-
chased from Wako Pure Chemical Industries, Ltd. (Osaka,
Japan).
2.2. Plant Material. Corni Fructus (Cornus officinalis Sieb. et
Zucc.) was purchased from Uchida Wakanyaku Ltd., Tokyo,
Japan.
2.3. Extraction, Fractionation, and Isolation. Corni Fructus
(1.9 kg) was crushed using a Warring blender and then
extracted with boiling water (10 L) for 10 min. After fil-
tration, the plant debris was extracted again with 5 L of
boiling water. The filtrates were combined and directly
applied to a Diaion HP20SS (8 × 42 cm) column. The
column was eluted with H2O containing increasing pro-
portions of MeOH (0–100%, 20% stepwise, each at 1 L)
and finally with 60% acetone. The eluate was monitored by
TLC and HPLC and separated into 4 fractions (Figure 1).
Fractions 1, 2, and 3 mainly contained sugars, 7-O-galloyl-d-
sedoheptulose, and iridoid glycosides, respectively, and were
not examined further because of the low-level activities of
these compounds. Fraction 4 contained polyphenols and
iridoid glycosides. The major polyphenols were polymeric
proanthocyanidins, which can be detected at the origin on
TLC analysis and as a broad hump on the HPLC baseline.
Fraction 4 (59.0 g) was subjected to Sephadex LH-20 col-
umn chromatography (10 × 24 cm) with H2O containing
increasing proportions of MeOH (0–100%, 20% stepwise,
each at 500 mL) and finally with 60% acetone to yield 9
fractions. Fractions 4-1 and 4-2 were separately applied to
Diaion HP20SS and Sephadex LH-20, and the fractions
containing the same compounds were combined to give
the fractions 4S-1, 4S-2, and 4S-3. The proanthocyanidins
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Figure 1: Fractionation of Corni Fructus extract.
were dispersed in the fractions (4S-1, 4S-3, 4-4, 4-62, 4-
71, and 4-8), and the total yield was about 1.2%. The
fractions containing proanthocyanidins were characterized
by thiol degradation [22], and the products were identified as
epigallocatechin-4-hydroxyethylthioether (23.5 min), epigal-
locatechin 3-O-gallate-4-hydroxyethylthioether (28.3 min),
epicatechin-4-hydroxyethylthioether (29.0 min), and epicat-
echin 3-O-gallate-4-hydroxyethylthioether (35.2 min) [18].
Fraction 4-5 was separated by Chromatorex ODS-MT
column chromatography to yield 6 fractions. The major
fraction, fraction 4-55, was identified as cornuside (7-O-
galloylsecologanol) [14] by 1H- and 13C-NMR compari-
son. Fraction 4-6 was subjected to Chromatorex ODS-MT
column chromatography to yield 5 fractions. The major
fractions, fractions 4-63 and 4-64, were identified as caffeic
and p-coumaric acids, respectively. Similar column chro-
matography of fraction 4-7 yielded 6 fractions. Fraction 4-
71 was composed of polymeric proanthocyanidins. Fraction
4-75 was identified as quercetin 3-O-glucuronide by 1H-
and 13C-NMR comparison. Fraction 4-8 mainly contained
polymeric proanthocyanidins along with a small amount
of ellagitannins. Fraction 4-9 gave a positive result in the
presence of NaNO2-AcOH reagent and yielded ellagic acid
and gallic acid on acid hydrolysis (2 mg/mL in 2% HCl,
100◦C, 2 h, identified by HPLC comparison), indicating that
this fraction was mainly composed of ellagitannins. The
chemical structure isolated from each fraction is shown in
Figure 2.
2.4. Determination of AGE. According to the method of Vin-
son and Howard [23], bovine serum albumin (10 mg/mL) in
50 mM phosphate-buffer (pH 7.4) with 0.02% sodium azide
to prevent bacterial growth was added to glucose (25 mM)
and fructose (25 mM). This reaction mixture was mixed
with different concentrations (12.5, 25, 50, 100 μg/mL) of
test sample or aminoguanidine and trolox. After incubation
at 37◦C for 2 weeks, the fluorescent reaction products
were assayed on a spectrofluorometric detector (Shimadzu
RF-550, Kyoto, Japan) with the excitation at 350 nm and
emission at 450 nm. All incubations were done in quadru-
plicate. The data are expressed in terms of the IC50 value
(concentration in μg/mL required to inhibit AGE formation
by 50%) calculated from the log-dose inhibition curve.
2.5. Determination of DPPH Radicals. In microwells, 100 μL
of an aqueous solution of the sample (control: 100 μL of
distilled water) was added to an ethanolic solution of DPPH
(60 μM) according to the method of Hatano et al. [6]. Seven
concentrations were prepared for each sample. After mixing
gently and leaving to stand for 30 min at room temper-
ature, the optical density was determined using a Microplate
Reader, model 3550-UV (Bio-Rad). The antioxidant activity





















































































Figure 2: Chemical structure of compounds isolated from Corni Fructus extract. ( ) has been presented the fraction which was isolated.
of each sample was expressed in terms of the IC50 (micromo-
lar concentration required to inhibit DPPH radical forma-
tion by 50%), calculated from the log-dose inhibition curve.
2.6. Statistical Analysis. Data are expressed as the mean ±
SEM. Simple regression analysis was performed to investigate
the correlation between DPPH radical-scavenging and AGE-
inhibiting activities using the Microsoft Excel 2003 statistical
package.
3. Results
3.1. AGE-Inhibiting Activity. The AGE-inhibiting activities
of 8 fractions of Corni Fructus showed wide variation.
Fractions 4-4 and 4-5 exerted higher inhibition compared
with aminoguanidine at all tested concentrations (Figure 3).
Next, subfractions from fractions 4-5, 4-6, and 4-7, and
fractions 4-8 and 4-9 were evaluated regarding their in-
hibitory activity. As shown in Table 1, most of the test sam-
ples inhibited AGE formation. Aminoguanidine showed low
or no inhibitory activities against AGE formation under
reactive conditions. Trolox, known as an antioxidant, showed
more marked inhibition compared with aminoguanidine.
Corni Fructus extract and iridoid glycoside components,
morroniside and loganin, showed low inhibitory activity as
well as aminoguanidine. On the other hand, the inhibitory
activity of 7-O-galloyl-d-sedoheptulose was higher than that
of other references. Fractions of Corni Fructus extract ranged
from a level comparable to Corni Fructus extract to the
higher level of 7-O-galloyl-d-sedoheptulose. Fraction 4-9,
containing ellagitannin, exerted the highest AGE-inhibiting
activity of all samples, as shown in Table 1.
3.2. DPPH Radical-Scavenging Activity. As shown in Table 1,
trolox showed DPPH radical-scavenging activity. Although
Corni Fructus extract and iridoid components showed
low or no DPPH radical-scavenging activity, 7-O-galloyl-d-
sedoheptulose showed a level comparable to trolox under
reactive conditions. Polyphenolic fractions of Corni Fructus
were quenched with DPPH radicals, and some fractions
exerted higher DPPH radical-scavenging activity compared
with trolox and 7-O-galloyl-d-sedoheptulose. Fraction 4-9,
containing ellagitannin, exerted the highest DPPH radical-
scavenging activity of all samples.
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Table 1: AGE-inhibiting and DPPH radical-scavenging activities of the fractions from Corni Fructus extract.
Sample Major constituents
AGE-inhibiting activity (%) DPPH radical-scavenging activity (%)
12.5 μg/mL 25 μg/mL 1 μg/mL 2 μg/mL
Fr. 4-74 Mixa 10.3± 1.0 12.6± 8.2 8.4± 0.5 14.4± 0.8
Fr. 4-56 Mixa 14.7± 0.6 25.7± 2.8 12.6± 0.6 15.7± 1.1
Fr. 4-65 Mixa −10.1± 9.0 31.9± 1.8 20.3± 0.3 41.0± 1.1
Fr. 4-53 Mixa + polymeric proanthocyanidins 11.9± 6.0 38.6± 1.3 21.1± 0.6 38.4± 0.3
Fr. 4-54 Mixa + polymeric proanthocyanidins 20.9± 6.0 35.7± 0.9 21.2± 0.9 41.7± 0.9
Fr. 4-75 Quercetin glucuronide 8.9± 4.0 55.3± 5.2 22.9± 1.3 48.7± 0.6
Fr. 4-64 p-Coumaric acid 14.6± 10.6 32.4± 7.5 23.6± 1.6 39.5± 1.3
Fr. 4-52 Mixa 20.3± 1.7 50.0± 1.8 24.1± 0.6 37.2± 0.4
Fr. 4-51 Mixa + polymeric proanthocyanidins 8.8± 3.8 35.2± 5.5 24.5± 1.5 39.0± 1.2
Fr. 4-76 Mixa 33.3± 5.8 72.3± 1.8 25.7± 1.1 48.0± 0.9
Fr. 4-55 Cornuside 13.0± 2.4 50.2± 1.0 28.3± 0.5 51.1± 0.3
Fr. 4-63
Caffeic acid + polymeric
proanthocyanidins
21.2± 4.7 69.6± 0.8 28.9± 0.3 67.1± 0.1
Fr. 4-62 Mixa + polymeric proanthocyanidins 27.3± 6.1 73.0± 0.7 35.3± 0.3 63.7± 0.6
Fr. 4-71 Polymeric proanthocyanidins 41.8± 2.9 76.1± 1.6 35.6± 1.3 64.1± 2.3
Fr. 4-72 Mixa + polymeric proanthocyanidins 40.5± 2.6 80.5± 1.8 39.6± 0.9 68.2± 0.5




75.0± 1.8 86.0± 0.5 47.3± 0.4 70.8± 1.8
Corni Fructus extract 9.2± 5.2 12.8± 0.5 2.8± 1.1 5.9± 1.4
Morroniside 5.9± 2.1 −0.2± 3.1 3.3± 0.3 2.1± 1.1
Loganin 4.0± 2.1 −0.6± 2.4 1.5± 2.2 −0.9± 1.6
7-O-Galloyl-d-
sedoheptulose
48.2± 3.3 61.9± 3.7 36.5± 0.7 59.6± 0.7
Trolox 23.2± 2.7 34.1± 2.1 33.8± 0.5 60.7± 1.0
Aminoguanidine −0.2± 1.5 8.6± 3.0 5.6± 2.1 0.8± 3.6
a
Mixture of low molecular weight compounds.
3.3. Correlation between AGE-Inhibiting and DPPH Radical-
Scavenging Activities. The correlation between AGE-inhib-
iting activity at a concentration of 12.5 μg/mL and DPPH
radical-scavenging activity at a concentration of 1 μg/mL
is shown in Figure 4 (), indicating a significant positive
correlation. Also, a similar positive correlation between AGE-
inhibiting activity at a concentration of 25 μg/mL and DPPH
radical-scavenging activity at a concentration of 2 μg/mL was
observed, as shown in Figure 4 ().
4. Discussion
Polyphenols are natural products that demonstrate antiox-
idative activity in the form of anti-carcinogenetic, anti-
cardiovascular disease, and antimelanogenic activities. In this
paper, we evaluated AGE-inhibiting and DPPH radical-
scavenging activities of fractions of Corni Fructus. The
results showed that fractions containing ellagitannins or
polymeric proanthocyanidins exerted marked DPPH radi-
cal-scavenging and AGE-inhibiting activities. The strong
inhibitory activities of fraction 4-4 (Figure 3) were also
attributable to the polymeric proanthocyanidins, which are
characterized by thiol degradation [22]. In the fractionation,
polymeric proanthocyanidins were dispersed into some frac-
tions obtained by Sephadex LH-20 column chromatography.
The reason is not clear; however, proanthocyanidin-pectin
complexation may be affected during separation because
Corni Fructus is from dried fruit and contains a large amount
of pectin [24].
The DPPH radical is stable and has been used as a tool
for radical-scavenging assays. In this study, some fractions
contained polymeric proanthocyanidins, and ellagitannins
exerted high-level DPPH radical-scavenging activity com-
pared with 7-O-galloyl-d-sedoheptulose. The free radical-
scavenging effects of polyphenols and related polyphe-
nols having an o-trihydroxyl (pyrogallol) structure (galloyl,
hexahydroxydiphenoyl groups in hydrolyzable tannins, a
galloyl group in acylated proanthocyanidins, and the B-
ring of some flavan-3-ols) were stronger than the effects of
unacylated proanthocyanidins [6, 7]. The scavenging activity
was elevated with an increase of the molecular weight [6].
The differences in DPPH radical-scavenging activity among
the fractions may be due to the molecular weight and rate of
galloylation. The antioxidant activity of hydrolyzable tannins
and tannic acid is mainly due to iron chelation rather than
hydroxyl radical scavenging [25]. In this study, fraction 4-9
exhibited the highest DPPH radical-scavenging and highest
AGE-inhibiting activities. This fraction included ellagitan-
nins and polymeric proanthocyanidins. Ellagitannins were
detected almost exclusively in this fraction and characterized
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Figure 4: Correlation between AGE-inhibiting and DPPH radical-
scavenging activities of Corni Fructus polyphenolic fractions.
The correlation between AGE-inhibiting activity at a concentra-
tion of 12.5 μg/mL and DPPH radical-scavenging activity at a
concentration of 1 μg/mL (), and AGE-inhibiting activity at a
concentration of 25 μg/mL and DPPH radical-scavenging activity
at a concentration of 2 μg/mL ().
by hydrolysis yielding ellagic acid; however, the structures
could not be identified due to difficulty of purification
and complexity of the composition. The highest activity of
fraction 4-9 could be due to their pyrogallol structure and
transition metal chelation. Further chemical investigation of
the ellagitannin fraction is now in progress.
In this study, trolox exerted high-level activity against
both DPPH radical scavenging and AGE inhibition. Trolox,
which is a water soluble analogue of α-tocopherol, has been
proven to be an antioxidant under a wide range of conditions
and test systems [26]. This result suggests that trolox inhib-
ited AGE formation by antioxidant activity including free
radical scavenging. The relationship between the DPPH
radical-scavenging and AGE-inhibiting activities of polyphe-
nolic fractions of Corni Fructus showed the same tendency
as the results for trolox. This suggested that polyphenolic
fractions of Corni Fructus also inhibited AGE formation by
antioxidant activity including free radical scavenging.
Both the DPPH radical-scavenging and AGE-inhibiting
activities of trolox were higher than those of aminoguani-
dine. The mechanism of aminoguanidine, which is one of
the AGE inhibitors, has been shown to involve the trapping
of reactive dicarbonyl species [27], antioxidant activity by
transition metal chelation [28], and other antioxidant activ-
ity including hydroxyl radical scavenging [28, 29]. Therefore,
potent antioxidant activity is expected to play an important
role in AGE inhibition.
Biological or physiological studies of polyphenolic con-
stituents of Corni Fructus are limited. In our previous stud-
ies, we reported the hepato- or reno-protective role of a low
molecular weight polyphenol, 7-O-galloyl-d-sedoheptulose,
on diabetes associated with AGE and oxidative stress in
streptozotocin-induced type 1 diabetic rats [17] and type 2
diabetic db/db mice [18]. The fraction containing polymeric
proanthocyanidins showed α-glucosidase-inhibiting activity
and suppressed plasma glucose levels after sucrose loading
[19]. In this study, marked AGE-inhibiting and DPPH
radical-scavenging activities were found in several fractions
containing polymeric proanthocyanidins. It is interesting
that polymeric proanthocyanidins show not only a high
AGE-inhibiting activity, but also DPPH radical-scavenging
activity, and the limited fractions exhibit high α-glucosidase-
inhibiting activity. This suggests that, in addition to 7-O-
galloyl-d-sedoheptulose, another active component may be
present in these polyphenolic fractions.
5. Conclusions
Some polyphenolic fractions of Corni Fructus exerted both
AGE-inhibiting and DPPH radical-scavenging activities in
vitro, suggesting the possibility of inhibiting AGE formation
in vivo.
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